SYSTEMS

GenoMed, a Next Generation DM (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today that it has named Professor Werner Dubitzky to its Science Advisory Board, a leader in the new field of Systems Biology. Werner Dubitzky received his BSc degree in electrical and communication engineering from the Augsburg University of Applied Science, Germany, in 1991 and his Ph.D. in artificial intelligence and machine learning from the University of Ulster, Northern Ireland, UK, in 1997. From January 2000 to December 2001 he spearheaded the data mining developments at the Intelligent Bioinformatics Systems Group at the German Cancer Research Center, Heidelberg, Germany. Since January 2002 he has held the Chair of Bioinformatics at the School of Biomedical Sciences, Faculty of Life and Health Science, at the University of Ulster at Coleraine, Northern Ireland, UK. He is Head of the Bioinformatics Research Group at the same institute. His current research interests include bioinformatics, systems biology, data and text mining, data warehousing, and grid technology. Dr. David Moskowitz, GenoMed's CEO, said, "I am delighted that Professor Dubitzky, who is an international leader in Systems Biology, has agreed to help us organize the cancer-causing genes we hope to soon have into pathways. Knowing disease pathways will let us plan the best place to ambush the disease, and which targets to make drugs against." Professor Dubitzky said, "I welcome the opportunity to apply our cutting edge machine protocols to a complex biological problem like uncovering the genetic pathways of common cancers. Although our work so far has been in mining gene expression data, our algorithms should lend themselves well to GenoMed's extensive SNP data."